| Expression pattern: |
UP |
| Associated gene: |
EIF4A3, TNFSF11 |
| Associated microRNA: |
miR-507 |
| Biological function: |
Promotes LUAD cell proliferation and viability and inhibits apoptosis; its knockdown suppresses proliferation/viability and enhances apoptosis. |
| Molecular mechanism: |
EIF4A3 binds circR-4225 precursor mRNA and promotes circR-4225 expression; circR-4225 sponges miR-507, relieving miR-507-mediated repression of TNFSF11. |
| Biological pathway or process: |
proliferation (promotes); apoptosis (inhibits); ceRNA regulation (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; RIP (RNA Immunoprecipitation); Clinical Sample Validation; Bioinformatics Analysis; Transfection; CCK8; EdU Staining; TUNEL; Luciferase Reporter Assay; Western Blot; Survival Analysis; Wound Healing Assay; Transwell Assay |
| Clinical significance: |
Potential molecular target for early diagnosis and treatment of LUAD. |
| Description: |
circR-4225 is up-regulated in LUAD tissues and promotes LUAD cell proliferation/viability while inhibiting apoptosis. Mechanistically, EIF4A3 promotes circR-4225 expression, and circR-4225 sponges miR-507 to up-regulate TNFSF11. |
| Confidence score: |
0.7552 |